Abstract
Objectives
To evaluate the ability of chest computed tomography (CT) to predict pulmonary hypertension (PH) and outcome in chronic heart failure with reduced ejection fraction (HFrEF).
Methods
We reviewed 119 consecutive patients with HFrEF by CT, transthoracic echocardiography (TTE) and right heart catheterization (RHC). CT-derived pulmonary artery (PA) diameter and PA to ascending aorta diameter ratio (PA:A ratio), left atrial, right atrial, right ventricular (RV) and left ventricular volumes were correlated with RHC mean pulmonary arterial pressure (mPAP) . Diagnostic accuracy to predict PH and ability to predict primary composite endpoint of all-cause mortality and HF events were evaluated.
Results
RV volume was significantly higher in 81 patients with PH compared to 38 patients without PH (133 ml/m2 vs. 79 ml/m2, p < 0.001) and was moderately correlated with mPAP (r=0.55, p < 0.001). Also, RV volume had higher ability to predict PH (area under the curve: 0.88) than PA diameter (0.79), PA:A ratio (0.76) by CT and tricuspid regurgitation gradient (0.83) and RV basal diameter by TTE (0.84, all p < 0.001). During the follow-up period (median: 3.4 years), 51 patients (43%) had HF events or died. After correction for important clinical, TTE and RHC parameters, RV volume (adjusted hazard ratio [HR]: 1.71, 95% CI 1.31–2.23, p < 0.001) and PA diameter (HR: 1.61, 95% CI 1.18–2.22, p = 0.003) were independent predictors of the primary endpoint.
Conclusion
In patients with HFrEF, measurement of RV volume and PA diameter on ungated CT are non-invasive markers of PH and may help to predict the patient outcome.
Key Points
• Right ventricular (RV) volume measured by chest CT has good ability to identify pulmonary hypertension (PH) in patients with chronic heart failure (HF) and reduced ejection fraction (HFrEF).
• The accuracy of pulmonary artery (PA) diameter and PA to ascending aorta diameter ratio (PA:A ratio) to predict PH was similar to previous studies, however, with lower cut-offs (28.1 mm and 0.92, respectively).
• Chest CT-derived PA diameter and RV volume independently predict all-cause mortality and HF events and improve outcome prediction in patients with advanced HFrEF.
Similar content being viewed by others
Abbreviations
- AUC:
-
Area under the curve
- BSA:
-
Body surface area
- CI :
-
Confidence interval
- FAC:
-
Fractional area change
- HFrEF:
-
Heart failure with reduced injection fraction
- IHD:
-
Ischemic heart disease
- IQR:
-
Interquartile range
- LA:
-
Left atrium
- LV:
-
Left ventricular or ventricle
- LVEF:
-
Left ventricular ejection fraction
- NIDCM:
-
Nonischemic dilated cardiomyopathy
- mPAP:
-
Mean pulmonary artery pressure
- PA:
-
Pulmonary artery
- PAP:
-
Pulmonary artery pressure
- PAWP:
-
Pulmonary artery wedge pressure
- PH:
-
Pulmonary hypertension
- PH-LHD:
-
Pulmonary hypertension due to left heart disease
- PVR:
-
Pulmonary vascular resistance
- RA :
-
Right atrium
- ROC:
-
Receiving operating curve
- RHC:
-
Right heart catheterization
- RV:
-
Right ventricular or right ventricle
- TR:
-
Tricuspid regurgitation
- TTE:
-
Transthoracic echocardiography
References
Simonneau G, Gatzoulis MA, Adatia I et al (2013) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 62:D34–D41
Galiè N, Humbert M, Vachiery JL et al (2016) 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 37:67–119
Vachiéry JL, Adir Y, Barberà JA et al (2013) Pulmonary hypertension due to left heart diseases. J Am Coll Cardiol 62:D100–D108
Ghio S, Gavazzi A, Campana C et al (2001) Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol 37:183–188
Grigioni F, Potena L, Galie N et al (2016) Prognostic implications of serial assessments of pulmonary hypertension in severe chronic heart failure. J Heart Lung Transplant 25:1241–1246
Costard-Jäckle A, Fowler MB (1992) Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol 19:48–54
Butler J, Stankewicz MA, Wu J et al (2005) Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation. J Heart Lung Transplant 24:170–177
Mehra MR, Kobashigawa J, Starling R et al (2006) Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006. J Heart Lung Transplant 25:1024–1042
Gavazzi A, Berzuini C, Campana C et al (1997) Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure. J Heart Lung Transplant 16:774–785
Ghio S, Temporelli PL, Klersy C et al (2013) Prognostic relevance of a non-invasive evaluation of right ventricular function and pulmonary artery pressure in patients with chronic heart failure. Eur J Heart Fail 15:408–414
Kjaergaard J, Akkan D, Iversen KK, Kober L, Torp-Pedersen C, Hassager C (2007) Right ventricular dysfunction as an independent predictor of short- and long-term mortality in patients with heart failure. Eur J Heart Fail 9:610–616
Bourantas CV, Loh HP, Bragadeesh T et al (2011) Relationship between right ventricular volumes measured by cardiac magnetic resonance imaging and prognosis in patients with chronic heart failure. Eur J Heart Fail 13:52–60
Mehra MR, Canter CE, Hannan MM et al (2016) The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. J Heart Lung Transplant 35:1–23
Freed BH, Collins JD, François CJ et al (2016) MR and CT Imaging for the Evaluation of Pulmonary Hypertension. JACC Cardiovasc Imaging 9:715–732
Kuriyama K, Gamsu G, Stern RG, Cann CE, Herfkens RJ, Brundage BH (1984) CT-determined pulmonary artery diameters in predicting pulmonary hypertension. Invest Radiol 19:16–22
Karazincir S, Balci A, Seyfeli E et al (2008) CT assessment of main pulmonary artery diameter. Diagn Interv Radiol 14:72–74
Ng CS, Wells AU, Padley SP (1999) A CT sign of chronic pulmonary arterial hypertension: the ratio of main pulmonary artery to aortic diameter. J Thorac Imaging 14:270–278
Mahammedi A, Oshmyansky A, Hassoun PM, Thiemann DR, Siegelman SS (2013) Pulmonary artery measurements in pulmonary hypertension: the role of computed tomography. J Thorac Imaging 28:96–103
Devaraj A, Wells AU, Meister MG et al (2008) The Effect of Diffuse Pulmonary Fibrosis on the Reliability of CT Signs of Pulmonary Hypertension. Radiology 249:1042–1049
Alhamad EH, Al-Boukai AA, Al-Kassimi FA et al (2011) Prediction of pulmonary hypertension in patients with or without interstitial lung disease: reliability of CT findings. Radiology 260:875–883
Devaraj A, Loveridge R, Bosanac D et al (2014) Portopulmonary hypertension: improved detection using CT and echocardiography in combination. Eur Radiol 24:2385–2393
Iyer AS, Wells JM, Vishin S, Bhatt SP, Wille KM, Dransfield MT (2014) CT scan-measured pulmonary artery to aorta ratio and echocardiography for detecting pulmonary hypertension in severe COPD. Chest 145:824–832
Shen Y, Wan C, Tian P et al (2014) CT-base pulmonary artery measurement in the detection of pulmonary hypertension: a meta-analysis and systematic review. Medicine (Baltimore) 93:e256
Devaraj A, Wells AU, Meister MG, Corte TJ, Wort SJ, Hansell DM (2010) Detection of pulmonary hypertension with multidetector CT and echocardiography alone and in combination. Radiology 254:609–616
Chan AL, Juarez MM, Shelton DK et al (2011) Novel computed tomographic chest metrics to detect pulmonary hypertension. BMC Med Imaging 11:7
Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16:233–270
Puntmann VO, Carr-White G, Jabbour A et al (2016) T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure. JACC Cardiovasc Imaging 9:40–50
Hicks KA, Tcheng JE, Bozkurt B et al (2015) ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). J Am Coll Cardiol 66:403–469
Meyer P, Filippatos GS, Ahmed MI et al (2010) Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure. Circulation 121:252–258
Rahimi K, Bennett D, Conrad N et al (2014) Risk prediction in patients with heart failure: a systematic review and analysis. JACC Heart Fail 2:440–446
Pocock SJ, Ariti CA, McMurray JJ et al (2013) Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. Eur Heart J 34:1404–1413
Dzudie A, Kengne AP, Thienemann F, Sliwa K (2014) Predictors of hospitalizations for heart failure and mortality in patients with pulmonary hypertension associated with left heart disease: a systematic review. BMJ Open 4:e004843
Karakus G, Kammerlander AA, Aschauer S et al (2015) Pulmonary artery to aorta ratio for the detection of pulmonary hypertension: cardiovascular magnetic resonance and invasive hemodynamics in heart failure with preserved ejection fraction. J Cardiovasc Magn Reson 17:79
Funding
The authors state that this work has not received any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Anne-Catherine Pouleur, MD, PhD
Conflict of interest
Pr Pouleur is Clinical Master Specialist of the Fondation Nationale de la Recherche Scientifique of the Belgian Government, FRSM.
The other authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
Statistics and biometry
Christophe de Meester kindly provided statistical advice for this manuscript and has significant statistical expertise.
Informed consent
Written informed consent was waived by the Institutional Review Board.
Ethical approval
Institutional Review Board approval was obtained.
Methodology
• retrospective
• diagnostic or prognostic study
• performed at one institution
Rights and permissions
About this article
Cite this article
Colin, G.C., Gerber, B.L., de Meester de Ravenstein, C. et al. Pulmonary hypertension due to left heart disease: diagnostic and prognostic value of CT in chronic systolic heart failure. Eur Radiol 28, 4643–4653 (2018). https://doi.org/10.1007/s00330-018-5455-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-018-5455-6